Synthesis and evaluation of new designed multiple ligands directed towards both peroxisome proliferator-activated receptor-γ and angiotensin II type 1 receptor-Reference-Cited by-同舟云学术

Synthesis and evaluation of new designed multiple ligands directed towards both peroxisome proliferator-activated receptor-γ and angiotensin II type 1 receptor

Published:2018-10 Issue: Volume:158 Page:334-352
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Meyer Maxime,Foulquier Sébastien^ORCID,Dupuis François,Flament Stéphane,Grimaud Linda,Henrion Daniel,Lartaud Isabelle,Monard Gérald,Grillier-Vuissoz Isabelle,Boisbrun Michel^ORCID

Funder

Lorraine Regional Council

Pharmacolor Association

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference56 articles.

1. Designed multiple ligands. An emerging drug discovery paradigm;Morphy;J. Med. Chem.,2005

2. Multi-target therapeutics: when the whole is greater than the sum of the parts;Zimmermann;Drug Discov. Today,2007

3. Designing multiple ligands – medicinal chemistry strategies and challenges;Morphy;Curr. Pharmaceut. Des.,2009

4. Shifting from the single to the multitarget paradigm in drug discovery;Medina-Franco;Drug Discov. Today,2013

5. Polypharmacology – foe or friend?;Peters;J. Med. Chem.,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Heterocyclic PPAR Ligands for Potential Therapeutic Applications;Pharmaceutics;2022-10-08

2. Triterpenic Acid Amides as a Promising Agent for Treatment of Metabolic Syndrome;Scientia Pharmaceutica;2020-12-29

3. Discovery of TD-0212, an Orally Active Dual Pharmacology AT1 Antagonist and Neprilysin Inhibitor (ARNI);ACS Medicinal Chemistry Letters;2018-12-03